A network meta-analysis to assess options for treatment intensification for patients with type 2 diabetes inadequately controlled on dual therapy

被引：0
|
作者：
Schroeder, M. [1 ]
Taieb, V. [2 ]
Pacou, M. [3 ]
Ho, S. [2 ]
Nielsen, A. T. [4 ]
Schubert, A. [5 ]
Neslusan, C. [6 ]
机构：
[1] Janssen UK, High Wycombe, Bucks, England
[2] Amaris, London, England
[3] Amaris, Paris, France
[4] Janssen Cilag, Birkerod, Denmark
[5] Janssen Cilag, Warsaw, Poland
[6] Janssen Global Serv LLC, Raritan, NJ USA
来源：
DIABETOLOGIA | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
727
引用
收藏
页码：S347 / S347
页数：1
相关论文
共 50 条
  • [31] Treatment intensification in patients with type 2 diabetes
    Barnett, Anthony H.
    [J]. DIABETES OBESITY & METABOLISM, 2008, 10 : III - III
  • [32] Tolerability and Effectiveness of Switching to Dulaglutide in Patients With Type 2 Diabetes Inadequately Controlled With Insulin Therapy
    Kim, Youngsook
    Huh, Ji Hye
    Lee, Minyoung
    Kang, Eun Seok
    Cha, Bong-Soo
    Lee, Byung-Wan
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [33] Dapagliflozin as Add-On Therapy in Asian Patients with Type 2 Diabetes Inadequately Controlled on Insulin
    Yang, Wenying
    Ma, Jianhua
    Li, Yiming
    Li, Yanbing
    Zhou, Zhiguang
    Kim, Jae Hyeon
    Zhao, June
    Ptaszynska, Agata
    [J]. DIABETES, 2017, 66 : A338 - A338
  • [34] Sodium-Glucose Co-Transporter 2 Inhibitors Compared with Sulfonylureas in Patients with Type 2 Diabetes Inadequately Controlled on Metformin: A Meta-Analysis of Randomized Controlled Trials
    Chen, Ze
    Li, Gerui
    [J]. CLINICAL DRUG INVESTIGATION, 2019, 39 (06) : 521 - 531
  • [35] Comparison of lixisenatide in combination with basal insulin vs other insulin regimens for the treatment of patients with type 2 diabetes inadequately controlled by basal insulin: Systematic review, network meta-analysis and cost-effectiveness analysis
    Men, Peng
    Qu, Shuli
    Luo, Wenting
    Li, Chaoyun
    Zhai, Suodi
    [J]. DIABETES OBESITY & METABOLISM, 2020, 22 (01): : 107 - 115
  • [36] Sodium-Glucose Co-Transporter 2 Inhibitors Compared with Sulfonylureas in Patients with Type 2 Diabetes Inadequately Controlled on Metformin: A Meta-Analysis of Randomized Controlled Trials
    Ze Chen
    Gerui Li
    [J]. Clinical Drug Investigation, 2019, 39 : 521 - 531
  • [37] Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials
    Shi, Qingyang
    Nong, Kailei
    Vandvik, Per Olav
    Guyatt, Gordon H.
    Schnell, Oliver
    Ryden, Lars
    Marx, Nikolaus
    Brosius III, Frank C.
    Mustafa, Reem A.
    Agarwal, Arnav
    Zou, Xinyu
    Mao, Yunhe
    Asadollahifar, Aminreza
    Chowdhury, Saifur Rahman
    Zhai, Chunjuan
    Gupta, Sana
    Gao, Ya
    Lima, Joao Pedro
    Numata, Kenji
    Qiao, Zhi
    Fan, Qinlin
    Yang, Qinbo
    Jin, Yinghui
    Ge, Long
    Yang, Qiuyu
    Zhu, Hongfei
    Yang, Fan
    Chen, Zhe
    Lu, Xi
    He, Siyu
    Chen, Xiangyang
    Lyu, Xiafei
    An, Xingxing
    Chen, Yaolong
    Hao, Qiukui
    Standl, Eberhard
    Siemieniuk, Reed
    Agoritsas, Thomas
    Tian, Haoming
    Li, Sheyu
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2023, 381
  • [38] Effect of Dapagliflozin in Patients with inadequately controlled Type 2 Diabetes with Metformin
    Pavlicek, V.
    [J]. DIABETOLOGE, 2011, 7 (01): : 37 - 38
  • [39] Comparison of glucose-lowering agents after dual therapy failure in type 2 diabetes: A systematic review and network meta-analysis of randomized controlled trials
    Zaccardi, Francesco
    Dhalwani, Nafeesa N.
    Dales, Jolyon
    Mani, Hamid
    Khunti, Kamlesh
    Davies, Melanie J.
    Webb, David R.
    [J]. DIABETES OBESITY & METABOLISM, 2018, 20 (04): : 985 - 997
  • [40] Dose titration of repaglinide in patients with inadequately controlled type 2 diabetes
    Kolendorf, K
    Eriksson, J
    Birkeland, KI
    Kjellström, T
    Hreidarsson, AB
    [J]. DIABETES RESEARCH AND CLINICAL PRACTICE, 2004, 64 (01) : 33 - 40
12345